| Authors: |
Stringer-Reasor EM; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., May JE; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Olariu E; Department of Medicine, Brookwood Baptist Health, Birmingham, AL, USA., Caterinicchia V; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Li Y; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Chen D; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Della Manna DL; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Rocque GB; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Vaklavas C; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Falkson CI; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Nabell LM; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Acosta EP; Department of Pharmacology/Toxicology, University of Alabama at Birmingham, Birmingham, AL, USA., Forero-Torres A; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Yang ES; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA. shyang@uabmc.edu.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, 1700 6th Avenue South, HSROC Suite 2232 (176F), Birmingham, AL, 35249, USA. shyang@uabmc.edu. |
